So, maybe, I will open it to the panelists and maybe Mr. Kreidler will mention--what should we be doing? And then, the others--what should we be doing to reign in these outrageous price increases from drug companies when there is not even a change in their product--it is at the end of their life cycle--and they are just profiting?
Peters questions how to address excessive drug price hikes without product changes.
Share & report
More from Gary Peters
To protect the rule of law, I vote no. The PRESIDING OFFICER. Pursuant to rule XII, no debate is permitted during a vote. The Senator will suspend. The clerk will continue to call the roll. The legislative clerk called the roll.
Mr. Speaker, I thank the gentleman for yielding. Mr. Speaker, I rise today to strongly oppose efforts to repeal the waste emissions charge, commonly known as the methane fee, which is a commonsense measure that benefits American industry…
I ask unanimous consent that the bill be considered read three times and passed and that the motion to reconsider be considered made and laid upon the table. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (S. 5639)…
Last Congress my bill, the Preventing Organizational Conflicts of Interest in Federal Acquisition Act, was signed into law.
Other voices in this conversation
